Camilla Harder Hartvig

Biography

Ms. Camilla Harder Hartvig, is the President of the Europe and Emerging Markets Business at Glenmark Pharmaceuticals Ltd. In this role, based out of London, Ms. Hartvig oversees the development & execution of strategy across Europe and the Emerging Markets (South East Asia, Pacific, Russia & CIS and Latin America), thereby driving growth of the company’s generics and branded pharmaceutical business in the region. Ms. Hartvig has more than twenty years of commercial experience in the global pharmaceutical industry. Prior to joining Glenmark, she has held global, regional and local business leadership positions in Pharmaceutical majors like Allergan (Actavis), Novartis and Astra Zeneca. Ms. Hartvig, a Danish national, holds a Master Degree in Business Science from the Copenhagen Business School specializing in International Marketing and Management and a Master’s degree in CEMS MIM from Ecole Des Hautes Etudes Commerciales (HEC), Paris. Her Bachelor’s in Business Science is also from Copenhagen Business School.

Research Interest

Business Science